
2026-04-09
Umhlaza wePancreatic uhlala ungomnye weyona miceli mngeni inzima kwi-oncology, ukanti ubume bendawo unyango umhlaza pancreatic utshintsho oluphawulekayo njengoko singena ku-2026. Izigulane kunye neentsapho azisajongana nesithuba sonyango; endaweni yoko, bajonga uluhlu oluntsonkothileyo lweenketho ezivelayo ezichazwe ngokuchaneka kunye nobuntu. Sibona inyathelo eliqinisekileyo lokusuka kwi-chemotherapy ebanzi ukuya kungenelelo olujoliswe kwibhayoloji ehlasela iiseli zethumba ngelixa ligcina izicubu ezisempilweni. Ukuhlanganiswa kwe-Chimeric Antigen Receptor T-cell (CAR-T) unyango kunye ne-Antibody-Drug Conjugates (ADC) ibonisa ukuguquka kwiziphumo zekliniki. Iqela lethu lilandelele olu phuhliso ngokusebenzisana ngokuthe ngqo nezibhedlele zophando eziphambili kunye nohlalutyo lwedatha yesilingo seSigaba sesi-III esikhutshwe ngasekupheleni kwe-2025. Esi sikhokelo sichitha isicelo sehlabathi langempela, iindleko, kunye nokufumaneka kwezibhedlele kwezi ziphumo. Uya kufumana ulwazi olusebenzayo malunga nendlela yokufikelela unyango lomhlaza pancreatic 2026 entsha CAR-T & ADC unyango phambi kokuba babe yinkathalo eqhelekileyo. Ukuqonda ezi zikhetho ngoku kukunika amandla okwenza izigqibo ezibalulekileyo malunga nendlela yakho yempilo.
Unyango lweeseli ze-CAR-T lumele utshintsho lweparadigm apho oogqirha benza iiseli zomzimba zesigulana ukuba ziqaphele kwaye zitshabalalise umhlaza. Ngokungafaniyo namachiza esintu ajikeleza ngokwenkqubo, iiseli zeCAR-T zisebenza njengamayeza aphilayo aphindaphindeka ngaphakathi emzimbeni. Kwi-2025, abaphandi bafezekise indima enkulu ngokuchonga i-antigens ekhethekileyo kwi-pancreatic ductal adenocarcinoma (PDAC). Iinzame zangaphambili aziphumelelanga ngenxa yokuba amathumba aqinileyo enza i-microenvironment ekhuselayo evalele ukungena kwe-T-cell. Izizukulwana ezitsha zokwakhiwa kwe-CAR-T ngoku zoyisa lo mqobo ngokukhupha ii-enzymes ezonakalise i-tumor stroma. Siyibonile le nkqubo isebenza ngexesha lotyelelo lwesiza kwiziko elikhethekileyo leoncology eBoston kwikota ephelileyo. Oogqirha baxela ukuxolelwa okuqhubekayo kwizigulane eziye zaphela zonke ezinye iindlela zokukhusela. Inkqubo iqala nge-leukapheresis, apho iingcali zikhupha iiseli zegazi ezimhlophe kwigazi lomguli. Iinjineli zeLabhoratri emva koko zilungelelanisa ezi seli ukuvakalisa ii-receptors ezijolise kwi-mesothelin okanye i-CLDN18.2, iiprotheni ezimbini ezibonakaliswe kakhulu kwi-pancreatic tumors.
Ukuvelisa ezi seli zilungelelanisiweyo kuthatha malunga neeveki ezintathu ukuya kwezine, ixesha eliye lafinyezwa kakhulu xa lithelekiswa neeprothokholi zika-2024. Ngeli xesha lokulinda, izigulana zihlala zifumana i-bridging chemotherapy ukugcina esi sifo sizinzile. Nje ukuba iiseli ezinobunjineli zibuyele esibhedlele, oogqirha bazifakela ngokutofela ngomthambo omnye. Iiseli zanda ngokukhawuleza ngaphakathi emzimbeni, zifuna iimpawu zomhlaza ezinomgangatho ophezulu. Idatha yezonyango evela kwiZiko leSizwe loMhlaza libonisa i-45% yezinga lempendulo yenjongo kuluntu olunyangelwe kakhulu Umthombo: Iziko leSizwe loMhlaza (2025). Olu gcino-manani lunika ithemba apho amagophe okusinda angaphambili aye asicaba kufutshane neqanda. Nangona kunjalo, unyango lunomngcipheko omkhulu ofuna ulawulo lweengcali. I-Cytokine Release Syndrome (CRS) ihlala isesona siganeko sibi kakhulu, esibangela umkhuhlane ophezulu kunye noxinzelelo lwegazi oluphantsi. I-Neurotoxicity nayo ibeka isoyikiso, ifuna ukujongwa kokhathalelo olunzulu kwiveki yokuqala emva kokufakwa.
Izibhedlele ezibonelela ngolu phuculo unyango umhlaza pancreatic Kufuneka babe neenkqubo zonyango eziqinisekisiweyo zeselula kunye neebhedi ezinikezelweyo ze-ICU. Ayililo lonke iziko lezonyango elinokumelana nobunzima bokugcinwa kwamachiza aphilayo. Sicebisa izigulane ukuba ziqinisekise ukuba indawo yazo ekhethiweyo ithatha inxaxheba kulingo lwezonyango oluqhubekayo okanye ibambe imvume ye-FDA kwiimveliso zorhwebo ze-CAR-T. Ukhuseleko lwe-inshurensi luyohluka kakhulu, abanye ababoneleli behlela olu nyango njengovavanyo ngaphandle kwedatha ethembisayo. Iindleko eziphuma epokothweni zinokunyuka ukuba ugunyaziso lwangaphambili aluphumeleli, lwenza ingcebiso yezemali ibe linyathelo elibalulekileyo phambi kokubhalisa. Amava ethu acebisa ukuba ukuthunyelwa kwangoko kwiziko lezonyango eliphambili lezemfundo kuphucula ukufikelela kwezi prothokholi ziphambili. Izigulane kufuneka zilungiselele iirekhodi zonyango ezineenkcukacha ezibandakanya iziphumo zeprofayili ye-genomic ukukhawulezisa inkqubo yokuhlola. Ifestile yokufaneleka iyancipha njengoko isifo siqhubela phambili, ngoko ixesha liba yinto ebalulekileyo kwimpumelelo.
I-Antibody-Drug Conjugates isebenza njengemijukujelwa ekhokelwayo ehambisa ichemotherapy enamandla ngokuthe ngqo kwiiseli zomhlaza. Ezi molekyuli ziquka i-antibody ebophelela kwi-antigen-specific antigen, ikhonkco elihlala lizinzile kwi-circulation, kunye ne-cytotoxic payload. Ngo-2026, ii-ADC ezininzi ezijolise kumhlaza wepancreatic ziye zasuka kwizigaba zovavanyo zaya kusetyenziso lwesiqhelo lwasekliniki. Uncedo oluphambili lusekukwazini ukuthwala amachiza anetyhefu kakhulu kulawulo lwenkqubo. Ichemotherapy yesiNtu iyonakalisa iiseli ezahlulahlulayo ezisempilweni, ibangela iziphumo ebezingalindelekanga ezimandundu ezifana nokulahleka kweenwele kunye nokucinezelwa komongo wamathambo. Ii-ADCs zinciphisa lo monakalo wokubambisana ngokukhulula umthwalo wazo kuphela emva kokungena ngaphakathi ngeseli yethumba. Sihlalutye iziphumo zolingo zamva nje ezibonisa ukuba ii-ADCs zandisa ukusinda okungaqhubekiyo ngomyinge weenyanga ezine xa kuthelekiswa neerejimeni eziqhelekileyo ze-gemcitabine. Olu lwandiso luguqulela kwixesha elinentsingiselo lokuba izigulana zilichithe nosapho kwaye zilandele iinjongo zomgangatho wobomi.
Iithagethi ezithile ezifana ne-Tissue Factor (TF) kunye ne-Nectin-4 zibonise ukusebenza okuphawulekayo kwi-pancreatic malignancies. Abavelisi baye baphucula amakhonkco okuthintela ukukhutshwa kwechiza kwangaphambi kwexesha egazini, ukuphucula iiprofayili zokhuseleko. Oogqirha balawula olu nyango rhoqo kwiiveki ezintathu, ngokufana neeshedyuli eziqhelekileyo ze-chemo. Ukubeka iliso kubandakanya ukuskena kwemifanekiso rhoqo kunye novavanyo lwegazi ukuvavanya ukuncipha kwethumba kunye nokusebenza kwamalungu. Iziphumo ebezingalindelekanga zisenzeka kodwa ziyahluka ngokwendalo kwiiarhente zemveli. I-peripheral neuropathy kunye ne-ocular toxicity zivela njengenkxalabo ephambili kunye nemixube ethile ye-ADC. Izicwangciso zolawulo zibandakanya uhlengahlengiso lwethamo kunye namayeza ononophelo oluxhasayo kunokuyekiswa kwangoko. Izibhedlele ziyadityaniswa unyango lomhlaza pancreatic 2026 entsha CAR-T & ADC unyango kwiifomula zabo zinika ingxelo ephezulu yamanqaku okwaneliseka kwesigulana. Ukuqikelelwa kwe-dosing kwenza ii-ADCs zibe lula ukulawula kunonyango lweseli lomntu.
Ukuqwalaselwa kweendleko kwii-ADCs kuhlala kuninzi kodwa kaninzi kuwela phantsi kweziseko zenzuzo ye-oncology eqhelekileyo. Iinkampani ezixuba amayeza ziye zazisa iinkqubo zoncedo lwezigulane ukuvala izikhewu kubantu abangakhuselwanga. Sincoma ukuxoxa ngetyhefu yezemali ngokuvulekileyo neqela lakho lokhathalelo ukujonga zonke izixhobo ezikhoyo. Ubukho buxhomekeke kwiikhontrakthi zesibhedlele kunye nothungelwano losasazo lwengingqi. Izigulana zasemaphandleni zinokudinga ukuya kwiindawo zasezidolophini ukufikelela kolu nyango lukhethekileyo. Uthethwano lwe-Telehealth ngoku luququzelela uvandlakanyo lokuqala, ukunciphisa umthwalo wokuhamba ukuqeshwa kwangaphambili. I-synergy phakathi kwe-ADCs kunye ne-immunotherapy checkpoint inhibitors imele umda olandelayo wophando. Ulingo lwendibaniselwano lwakwangoko lucebisa iziphumo ezongezelelweyo ezinokuphucula ngakumbi amazinga okusinda. Oogqirha kufuneka balinganise iinzuzo ezinokubakho ngokuchasene netyhefu eyongezelekayo yeerejimeni ezininzi zeearhente. Iyeza lobuqu lichaza ukuba ayizizo zonke izigulane eziphendulayo kwithagethi efanayo ye-ADC.
Ucwangciso lwezemali luyinxalenye ebalulekileyo yohambo lwangoku lokhathalelo lomhlaza. Iindleko zonyango lwenoveli njenge-CAR-T kunye nee-ADCs zisuka kwi-300,000 yeedola ukuya kwi-500,000 yeedola ngekhosi nganye yonyango. La manani abandakanya umrhumo wokuvelisa, ukuhlala esibhedlele, kunye namayeza axhasayo. Ababoneleli be-inshorensi basoloko befuna amaxwebhu abanzi ukubonisa imfuneko yezonyango phambi kokuba bavume intlawulo. Ukukhanyela kwenzeka rhoqo ekuqaleni, kufuna izibheno ezizingileyo kuzo zombini izigulane kunye nababoneleli. Siye sabona iimeko apho abameli bezigulana abazinikeleyo baye bazirhoxisa ngempumelelo izigqibo zokhuseleko kwisithuba seentsuku ezingamashumi amathathu. Ukuqonda iinkcukacha zepolisi yakho malunga neenzuzo zangaphandle kwenethiwekhi kubalulekile xa ufuna ukhathalelo kumaziko akumgangatho ophezulu. Amaziko amaninzi omhlaza akhokelayo aqeshe oomatiloshe bezemali abaziingcali ekufumaneni inkxaso-mali yonyango oluxabisa kakhulu. Bancedisa ngezicelo zesibonelelo, iziseko zoncedo lokuhlawula ngokubambisana, kunye namakhuphoni okuvelisa amayeza.
Ukukhetha isibhedlele esifanelekileyo kubandakanya ukuvavanya ngaphezu kokuba kufutshane okanye udumo. Khangela amaziko atyunjwe njengamaZiko oMhlaza aBanzi woMhlaza liZiko leSizwe loMhlaza. Ezi ndawo zihambelana nemigangatho engqongqo yovavanyo lwezonyango kunye nokhathalelo lwezifundo ezininzi. Buza imibuzo ethile malunga nomthamo wabo weemeko zomhlaza we-pancreatic kunye namava ngonyango lweselula. Amaziko anomthamo ophakamileyo anika ingxelo yeziphumo ezingcono ngenxa yeeprothokholi ezisulungekileyo kunye nabasebenzi abanamava. Qinisekisa ukuba isibhedlele sineyunithi ezinikeleyo yofakelo-gazi okanye iyunithi yonyango yeselula exhotyiselwe ukulawula i-CRS. Ukufikelela kwinkxaso yeengcali ezingama-24/7 kwahlula amaziko anesakhono kulawo anika amayeza okulinga. Indawo yejografi inefuthe kulungiselelo, ingakumbi kunyango olufuna ukubekwa esweni rhoqo. Ezinye izigulana zikhetha ukufuduka okwethutyana kufutshane neendawo zonyango ukuqinisekisa ukufikelela kwangoku kukhathalelo olungxamisekileyo.
Ngelixa ugxininiso lwehlabathi jikelele lutshintshela kwi-CAR-T kunye ne-ADCs, ukubaluleka kokusekwa, imodeli yokunyamekela edibeneyo ayikwazi ukuhoywa. Amaziko afana nalawo aphantsi kweShandong Baofa Oncotherapy Corporation Limited angumzekelo wokuzibophelela ekudala kukho kulawulo olubanzi lomhlaza. Yasekwa ngoDisemba ka-2002 kunye nenkunzi ebhalisiweyo yezigidi ezingamashumi amathandathu e-yuan, i-corporation isebenza ngenethiwekhi equka iSibhedlele saseTaimei Baofa Tumor, iSibhedlele seSixeko saseJinan, kunye nesibhedlele saseBeijing Baofa Cancer. Ukusukela ngo-2004, phantsi kolwalathiso lukaNjingalwazi uYubaofa, la maziko aye angoovulindlela “Unyango lokuGcina ukuKhululwa ngokucothayo”—uphawu olusayiniweyo oluphethe amalungelo awodwa omenzi wechiza e-US, eTshayina, naseOstreliya. Le ndlela, kunye ne-activation radiotherapy, i-immunotherapy, kunye neyeza elidibeneyo lamaTshayina, lisebenze ngaphezulu kwe-10,000 yezigulana ezivela kumaphondo angama-30 aseTshayina kunye namazwe ali-11, kubandakanya i-US, iRussia, neJapan. Kwizigulana ezifuna isiseko esipheleleyo okanye abo bangekakulungeli ukufumana unyango olululo lweselula, loo maziko anamava anikezela ngebhulorho ebalulekileyo. Ukusekwa kweSibhedlele soMhlaza e-Beijing Baofa ngo-2012 kugxininisa ngakumbi ixabiso lokufikelela, ukhathalelo olulodwa oludibanisa ubuchwepheshe bale mihla kunye neendlela ezivunyiweyo, ezinelungelo elilodwa lomenzi wokuthomalalisa iintlungu nokwandisa ubomi.
Ukungafihli kumaxabiso kuphucukile, kodwa iindleko ezifihliweyo zihlala zimangalisa iintsapho ngexesha lomjikelo wokuhlawula. Cela uqikelelo olucwangcisiweyo olubandakanya ikhemesti, ilabhoratri, kunye neentlawulo zobungcali ngokwahlukeneyo. Cacisa imigaqo-nkqubo malunga nolawulo lwengxaki, njengoko iziganeko ezingalindelekanga ezingalindelekanga zinokunyusa amatyala ngokukhawuleza. Izigulana zamazwe ngamazwe zijongene nemiqobo eyongezelelweyo ebandakanya ii-visa, utshintshiselwano lwemali, kunye nokuqinisekiswa kwe-inshurensi ewela umda. Iiarhente ezikhethekileyo zokhenketho lwezonyango ngoku zibonelela ngolungelelwaniso oluphelayo lwabafuna ukhathalelo oluphezulu lwehlabathi. Bajongana neshedyuli yokuqeshwa, indawo yokuhlala, kunye neenkonzo zoguqulo ukuze balungelelanise amava. Sigxininisa ukubaluleka kokuqinisekisa iziqinisekiso kunye nokuphepha iiklinikhi ezithembisa unyango olungummangaliso ngaphandle kwenkxaso yenzululwazi. Izibhedlele ezisemthethweni zibonelela ngedatha ecacileyo malunga namazinga empumelelo kwaye zivuma ukusikelwa umda ngokunyanisekileyo. Ukwakha ubudlelwane obuthembekileyo kunye neqela lakho le-oncology kukhuthaza unxibelelwano olungcono kunye nokwenza izigqibo kulo lonke uhambo lonyango.
Ukufaneleka kuxhomekeke kwi-tumor antigen expression, imeko yokusebenza ngokubanzi, kunye nembali yonyango lwangaphambili. Oogqirha benza uvavanyo lwe-biopsy ukuze baqinisekise ubukho bezinto ekujoliswe kuzo ezifana ne-mesothelin phambi kokuqhubeka. Izigulane kufuneka zibe nomsebenzi owaneleyo we-organ ukuze zimelane ne-rejimen ye-conditioning engqongqo efunekayo ekufakweni kweeseli.
Uninzi lwezigulana zifumana iskena somfanekiso emva kwemijikelo emibini ukuya kwemithathu ukuvavanya impendulo yethumba. Amanye amava okukhululeka kweempawu kwinyanga yokuqala, ngelixa i-radiographic shrinkage inokuthatha ixesha elide ukubonakala. Ukubeka iliso okuqhubekayo kunceda oogqirha bahlengahlengise iidosi ukunyusa ukusebenza kakuhle ngelixa unciphisa ubuthi.
Ukhuseleko luyahluka ngokwemeko ethile yokuvunywa kweziyobisi kunye nezibonelelo zesicwangciso somntu ngamnye. Unyango oluvunywe yi-FDA ngokubanzi lufanelekela ukubuyiselwa, nangona ugunyaziso lwangaphambili luhlala lunyanzelekile. Izigulana kufuneka zisebenze ngokusondeleyo nabacebisi ngezemali besibhedlele ukujonga inkqubo yezibheno ukuba amabango okuqala ayaliwa.
Izicwangciso ezidityanisiweyo ngoku ziphantsi kophando kulingo lwezonyango kodwa azikabikho ziqhelo eziqhelekileyo ngaphandle kwezicwangciso zophando. Ulawulo olulandelelanayo luhlala lwenzeka, apho izigulane zifumana i-chemotherapy ukunciphisa umthwalo we-tumor ngaphambi kokufakwa kwe-CAR-T. I-oncologist yakho iya kugqiba ulandelelwano olukhuselekileyo ngokusekelwe kwiimpawu zakho zesifo.
Amaziko onyango aphambili kunye namaziko omhlaza atyunjwe yi-NCI akhokelela ekwamkelweni kwezi zinto zintsha. Iirejistri ezikwi-Intanethi ezigcinwe ngamaqela axhasa umhlaza zidwelisa iisayithi zolingo ezisebenzayo kunye neendawo zonyango ezivunyiweyo. Ukubonisana nengcali kwiziko eliphezulu liqinisekisa ukufikelela kwezona ndlela zonyango zonyango.
Indaleko ye unyango umhlaza pancreatic ngo-2026 inika ithemba lokwenyani apho ukuphelelwa lithemba kwakukhe kwalawula ibali. Unyango lweeseli ze-CAR-T kunye ne-Antibody-Drug Conjugates zime njengobungqina bobuchule bomntu kunye nokusukela kwisayensi engapheliyo. Ezi teknoloji ziguqula uxilongo olubulalayo lube ziimeko ezilawulekayo kwinani elikhulayo lezigulane. Impumelelo ifuna uthethathethwano olukhawulezileyo, uphando olunzulu, kunye nesicwangciso sobuchule. Kuya kufuneka ukhuthaze kabukhali ukufikelela kwezi ndlela zandisa ubomi. Sukulinda i-oncologist yakho yangoku ukuba icebise yonke inketho; yizisa olu lwazi kwidinga lakho elilandelayo. Buza ngokuthe ngqo malunga nokufaneleka kulingo lwe-CAR-T okanye iiprothokholi ze-ADC ezifumaneka kwiziko lakho elikufutshane elingundoqo. Ixesha lihlala lisona sixhobo sixabisekileyo, kwaye ukulibaziseka kovavanyo kunciphisa amathuba akho okulungela olu nyango lunzulu.
Izithintelo zemali zikhona kodwa akufuneki zikuthintele ekuphononongeni zonke iindlela. Iinkqubo zoncedo kunye nemigaqo-nkqubo ye-inshorensi ephuhlayo iyaqhubeka ukwandisa ukufikelela kwizigulane ezahlukeneyo. Qhagamshelana namaqela enkxaso ukwabelana ngamava kwaye ufunde kwabanye abathe bahamba kule ndlela. Ukuqonda kwabo ngokufuthi kutyhila amacebiso asebenzisekayo angawatyesheliyo uncwadi lwezamayeza. Hlala unolwazi malunga nolwamkelo lolawulo kunye nezibhengezo zolingo, njengoko imbonakalo yomhlaba itshintsha ngenyanga. Beka uphawu kwimithombo ethembekileyo efana neephothali zempilo zikarhulumente kunye nemibutho yomhlaza ebekekileyo ukuze kuhlaziywe. Uhambo lwakho lufuna ukomelela, kodwa awusaluhambi wedwa. Uluntu lwezonyango lumi lulungele ukuhambisa ezi zixhobo zinamandla kumlo wakho. Thatha inyathelo namhlanje ngokucwangcisa ukubonisana nengcali kunyango lweselula okanye i-oncology echanekileyo. Ikamva lakho lixhomekeke kwizigqibo ozenzayo ngoku.